Skip to content

PTSD research published in 2021

Page 2 of 3: studies 21 to 40 of 58, newest first. Back to the PTSD overview

Studies

Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders

Canadian Journal of Health Technologies June 24, 2021 Yi‐sheng Chao, Jennifer Horton 5 citations

Two systematic reviews, 3 randomized controlled trials, and 2 single-arm safety trials were identified that evaluated several combinations of psychedelic-assisted psychotherapy. Psilocybin was the psychedelic most tested. Other psychedelics identified in the systematic reviews and primary studies were 3,4-methylenedioxymethamphetamine (or MDMA), lysergic acid diethylamide (or LSD), ayahuasca...

Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder

Journal of Humanistic Psychology June 23, 2021 Julie B. Wang, Jessica Lin, Leah Bedrosian et al. 22 citations

Background: Posttraumatic stress disorder (PTSD) is a debilitating mental health condition associated with serious adverse health outcomes and functional impairment. Previous MDMA–assisted therapy (MDMA-AT) studies have shown promising results in single site studies. Two open-label studies tested this modality in multisite clinical trials to assess the feasibility of scaling this manualized...

DOI: 10.1177/00221678211023663 (opens in new tab) Psychedelic therapy PTSD Treatment Trauma therapy Mental health treatment +15

Levels of emotional exhaustion and its relationship with depression and posttraumatic stress disorder in ICU nurses: the moderating effect of mindfulness

Di-san junyi daxue xuebao June 18, 2021 LU Fang, XU Yuanyuan, YU Yongju et al.

Objective To investigate the level of emotional exhaustion and its relationship with depression and posttraumatic stress disorder symptoms in intensive care unit (ICU) nurses and explore the moderating effects of mindfulness. Methods From March, 2016 to April 2017, we conducted a survey of the levels of emotional exhaustion, mindfulness, depression and posttraumatic stress disorder among 500...

DOI: 10.16016/j.1000-5404.201901097 (opens in new tab) Full text (opens in new tab) Mindfulness Emotional exhaustion Depressive symptom Posttraumatic stress disorder +2

Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA Sequencing

Research Square June 15, 2021 Dennis Parker Kelley, Katy Venable, Gerald Billac et al. 1 citation preprint

Abstract Post-traumatic stress disorder (PTSD) is associated with cognitive deficits, oxidative stress and inflammation. N,N-dimethyltryptamine (DMT) is a known neuroprotective, antioxidant, anti-inflammatory, and psychoplastogen with antidepressant effects. Therefore, we tested the capacity of DMT, the monoamine oxidase inhibitor (MAOI) harmaline, and “pharmahuasca” (DMT + harmaline) to reduce...

DOI: 10.21203/rs.3.rs-602961/v1 (opens in new tab) Full text (opens in new tab) Harmaline Oxidative stress Neuroprotection Pharmacology +5

Ketamine for the multivariate effect of PTSD: Systematic review and meta-analysis

medRxiv Preprint Server June 13, 2021 Rui Du, Kun Niu, Guofang Lu et al. preprint

The aim of this systematic review and meta-analysis was to examine the efficacy, anti-effect of ketamine (intervention) for post-traumatic stress disorder (PTSD) patients during analgesia proceeding and mental illness treatment methods, in comparison with control (midazolam, opioid, saline or placebo). The bibliographic databases Cochrane, Embase, Pubmed and Web of Science were searched from...

The eight limbs of yoga can be maintained in a veteran friendly yoga program

International Journal of Yoga June 2, 2021 Arlene A Schmid, Elizabeth A Sternke, Ai-Nghia L Do et al.

Background: Posttraumatic stress disorder (PTSD) may occur after a traumatic event and has deleterious effects on individuals, including decreased quality of life and function. Yoga is an intervention that may help with the management of PTSD symptoms, however yoga interventions in research studies frequently only include postures and breathwork, not all eight limbs of yoga. Aims and...

Written exposure therapy and app-delivered mindfulness-based meditation for PTSD and subthreshold PTSD in China: Design of a randomized controlled trial.

Contemporary Clinical Trials Communications June 2021 Muyang Li, Bingsu Wang, Qiang Chen et al.

Posttraumatic stress disorder (PTSD) and subthreshold PTSD are still major global concerns, especially in developing areas short of mental health resources. Written exposure therapy (WET), a brief 5-session treatment, has been found to be effective in reducing PTSD symptoms, but no studies have examined it in an Eastern context. Mindfulness-based meditation mobile application may be a promising...

DOI: 10.1016/j.conctc.2021.100729 (opens in new tab) Full text (opens in new tab) Chinese Gq-5, gratitude questionnaire-5 Hpa-axis, hypothalamic–pituitary–adrenal axis Mba, mindfulness-based application +9

[Development and Evaluation of Resilience Enhancement Program Applying Mindfulness Meditation in Patients with Ileostomy].

Journal of Korean Academy of Nursing June 1, 2021 Jee Hye Shin, Ja Yun Choi

The purpose of this study was to develop a resilience enhancement program applying mindfulness meditation (REP-MM) and evaluate the effects of the program on post-traumatic stress (PTS), resilience, and health-related quality of life (HRQoL) in patients with ileostomy. The REP-MM was developed by combining the resilience enhancement program with mindfulness meditation according to four...

Lucid Dreams in Veterans With Posttraumatic Stress Disorder Include Nightmares

Dreaming June 1, 2021 K. Miller, R. Ross, Gerlinde C. Harb

A previous study in military veterans with posttraumatic stress disorder (PTSD) and recurrent nightmares found a high prevalence of lucid dreaming (LD), the awareness while a dream continues that one is dreaming, and an “LD profile” characterized by frequent dream awareness and rare dream content control. Given the importance of the nightmare disturbance in PTSD, this study assessed with...

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Nature Medicine June 1, 2021 Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. 965 citations

Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with...

DOI: 10.1038/s41591-021-01336-3 (opens in new tab) Full text (opens in new tab) PTSD Treatment MDMA Therapy Clinical trials Mental health breakthrough

Lucid Dreams in Veterans With Posttraumatic Stress Disorder Include Nightmares.

Dreaming June 1, 2021 Katherine E Miller, Richard J Ross, Gerlinde C. Harb

A previous study in military veterans with posttraumatic stress disorder (PTSD) and recurrent nightmares found a high prevalence of lucid dreaming (LD), the awareness while a dream continues that one is dreaming, and an "LD profile" characterized by frequent dream awareness and rare dream content control. Given the importance of the nightmare disturbance in PTSD, this study assessed with...

Military-related posttraumatic stress disorder and mindfulness meditation: A systematic review and meta-analysis

Chinese journal of traumatology = Zhonghua chuang shang za zhi May 18, 2021 Luna Sun, Jingwen Gu, Lijun Huang et al.

Purpose Posttraumatic stress disorder (PTSD) is a significant global mental health concern, especially in the military. This study aims to estimate the efficacy of mindfulness meditation in the treatment of military-related PTSD, by synthesizing evidences from randomized controlled trials. Methods Five electronic databases (Pubmed, EBSCO Medline, Embase, PsychINFO and Cochrane Library) were...

The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis

Cureus May 17, 2021 Sarah Tedesco, Ganeya Gajaram, Shahzad Chida et al. 31 citations

Background: 3,4-methylenedioxymethamphetamine (MDMA), known recreationally as "Molly" or "Ecstasy", is a triple monoamine reuptake inhibitor. MDMA specifically acts as a weak 5-HT1 and 5-HT2 receptor agonist, targeting 5-HT2A, 5-HT2B, and 5-HT2C receptors. Its potential use for therapeutic purposes with these pharmacological profiles remains a controversial subject. Studies have shown the...

Psychedelic‐assisted therapy considered ‘breakthrough’ treatment for PTSD

Mental Health Weekly May 17, 2021 Valerie A. Canady 1 citation

New research involving the use of psychedelic‐assisted therapy is showing promise and significant implications for patients with severe, chronic post‐traumatic stress disorder (PTSD) and could potentially move the needle further toward Food and Drug Administration (FDA) approval, say researchers from the Multidisciplinary Association for Psychedelic Studies (MAPS).

DOI: 10.1002/mhw.32791 (opens in new tab) Psychedelic therapy PTSD Treatment Trauma therapy Chronic PTSD Relief +14

Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder.

Brain and Behavior May 14, 2021 Katsumasa Sogo, Masanobu Sogo, Yoshie Okawa

Introduction: Following a case study on scopolamine butyl bromide, an anticholinergic drug, we studied the effect of a central anticholinergic drug on post-traumatic stress disorder (PTSD)-related flashbacks and nightmares. Methods: We administered trihexyphenidyl (TP) to 34 patients with refractory PTSD-related nightmares and flashbacks (open-label trial [n = 22]; single-blind trial [n = 12]),...

DOI: 10.1002/brb3.2147 (opens in new tab) Full text (opens in new tab) PTSD Humans Trihexyphenidyl Cholinergic antagonists +7

Combining Ketamine and Internet-Based Cognitive Behavioral Therapy for the Treatment of Posttraumatic Stress Disorder: Protocol for a Randomized Controlled Trial

JMIR Research Protocols May 11, 2021 A. Philipp-Muller, Taras Reshetukha, Gustavo Vazquez et al.

Background Over one third of patients with posttraumatic stress disorder (PTSD) do not respond to current interventions. Ketamine presents a potential treatment option; however, its effects are temporary. Administering ketamine alongside psychotherapy is one potential means of prolonging its effects; however, only a few studies have investigated this treatment method to date, and none have...

Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence

medRxiv Preprint Server April 10, 2021 Agnes Norbury, Sarah B. Rutter, Abigail B. Collins et al. 1 citation preprint

Promising initial data indicate that the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine may be beneficial in post-traumatic stress disorder (PTSD). Here, we explore the neural correlates of ketamine-related changes in PTSD symptoms, using a rich battery of functional imaging data (two emotion-processing tasks and one task-free scan), collected from a subset of participants...

Loving-Kindness Meditation vs Cognitive Processing Therapy for Posttraumatic Stress Disorder Among Veterans

JAMA Network Open April 1, 2021 David J. Kearney, Carol A. Malte, Meghan Storms et al.

Key Points Question Is group loving-kindness meditation noninferior to group cognitive processing therapy for treatment of posttraumatic stress disorder (PTSD) among veterans? Findings In this randomized clinical trial, 184 veterans with PTSD were assigned to group loving-kindness meditation or group cognitive processing therapy; the differences in the decrease from baseline to 6-month...

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD

European Psychiatry April 1, 2021 B. Van der Kolk

Introduction Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Previous research has led to the designation of 3,4-methylenedioxymethamphetamine (MDMA) as a Breakthrough Therapy for treatment of post-traumatic stress disorder (PTSD) when administered as an adjunct to psychotherapy....